Core Viewpoint - The China Securities Regulatory Commission (CSRC) has issued supplementary material requirements for six companies, including Shenzhen Sifang Precision Information Co., Ltd., which is preparing to submit its listing application to the Hong Kong Stock Exchange by December 24, 2025 [1] Group 1: Company Overview - Shenzhen Sifang Precision Information Co., Ltd. specializes in providing comprehensive business solutions for financial institutions, including customized software development and operational services [1] - The company's main products include consulting services, product and solution offerings, cloud delivery operations, software development, technical maintenance, and system integration services [1] Group 2: Regulatory Requirements - The CSRC has requested Shenzhen Sifang Precision to clarify whether the raised funds involve domestic and overseas investment projects and to detail the relevant approval, authorization, or filing procedures [1] - The company is also required to explain its overall overseas operations in accordance with the "Guidance on Regulatory Rules - No. 2 for Overseas Issuance and Listing" [1]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has issued supplementary material requirements for overseas listing applications from 15 companies, focusing on compliance with foreign investment policies and operational legality [1][2][3]. Group 1: Supplementary Material Requirements - For Kid Wang, the company must clarify the start date and specifics of its value-added telecommunications services, foreign ownership limits, and compliance with foreign investment policies post-listing [5]. - For Qianli Technology, the company needs to provide updates on the transfer of shares related to the agreement with Lifan Holdings and confirm compliance with the Shanghai Stock Exchange [9]. - For Nanjing Qingtian, the company is required to align its listing plan with regulatory guidelines and disclose details about significant litigation [14]. Group 2: Compliance and Legal Opinions - For Zhenqu Technology, the company must explain the legality of shareholding arrangements and provide a list of past capital increases and share transfer prices, ensuring no irregularities exist [24]. - For Dafeng Gardening, the company needs to justify the establishment of a new listing entity in the Cayman Islands and confirm compliance with foreign investment reporting obligations [38]. - For Chengyi Biology, the company must clarify the shareholding structure and any potential changes in control, as well as the implications of special shareholder rights [40]. Group 3: Business Operations and Models - For Kid Wang, the company is required to describe its business model and the specific applications of AI large models [6]. - For Qianli Technology, the company must detail its business operations, including data processing and whether it complies with foreign investment restrictions [10]. - For Nanjing Qingtian, the company is asked to explain its involvement in AI large models and the operational status of its online platforms [15].

Group 1 - The core viewpoint of the article is that the China Securities Regulatory Commission (CSRC) has requested additional documentation from Sifang Jingchuang regarding its overseas listing application, specifically concerning the use of raised funds and compliance with relevant approval processes [1] - Sifang Jingchuang has submitted its listing application to the Hong Kong Stock Exchange, with CMB International and Guosen Securities (Hong Kong) acting as joint sponsors [1] - The company is a fintech service provider focused on the Greater Bay Area, offering software development, consulting, and system integration services to banks, regulatory bodies, and other financial institutions in mainland China, Hong Kong, and Southeast Asia [1] Group 2 - The CSRC's request aligns with the requirements outlined in the "Regulatory Rules Application Guidelines - Overseas Issuance and Listing Class No. 2," which necessitates a comprehensive explanation of the issuer's overall overseas operations [1] - The company aims to support the ongoing digital transformation of financial institutions through its services [1]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has announced additional requirements for the overseas listing application of Sifang Jingchuang, focusing on the use of raised funds and compliance with relevant approval processes [1] Group 1: Company Overview - Sifang Jingchuang is a financial technology service provider rooted in the Greater Bay Area, specializing in software development, consulting, and system integration services for banks, regulatory agencies, and other financial institutions in mainland China, Hong Kong, and Southeast Asia [1] - The company is actively supporting the digital transformation of its clients in the financial sector [1] Group 2: Regulatory Context - The CSRC has requested Sifang Jingchuang to clarify whether the raised funds are related to domestic or overseas investment projects and to detail the approval, authorization, or filing procedures followed [1] - The company submitted its listing application to the Hong Kong Stock Exchange on December 24, 2025, with CMB International and Guosen Securities (Hong Kong) acting as joint sponsors [1]

Group 1 - The core viewpoint of the article is that the China Securities Regulatory Commission (CSRC) has requested Sifang Jingchuang (300468) to provide supplementary materials regarding its overseas fundraising and related approval processes [1] - Sifang Jingchuang has submitted a listing application to the Hong Kong Stock Exchange, with CMB International and Guosen Securities (Hong Kong) acting as joint sponsors [1] - The company is a fintech service provider focused on the Greater Bay Area, offering software development, consulting, and system integration services to banks, regulatory bodies, and other financial institutions in mainland China, Hong Kong, and Southeast Asia [1] Group 2 - The CSRC's requirements include clarifying whether the raised funds are related to domestic or overseas investment projects and detailing the overall situation of the issuer's overseas operations [1] - The company aims to assist financial institutions in their ongoing digital transformation efforts [1]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has released a report on the status of domestic companies' overseas securities issuance and listing applications, indicating several companies are in various stages of the IPO process in Hong Kong [1]. Group 1: Companies and Their IPO Status - Sifang Precision (300468.SZ) has submitted materials for a Hong Kong IPO and has received acceptance from the CSRC [1][2]. - Zhenqu Technology is also in the process of applying for a Hong Kong IPO, with materials accepted by the CSRC [1][2]. - Jingze Biopharmaceutical (Hefei) has its Hong Kong IPO application in a supplementary materials status [1][2]. - Weili Zhibo-B (09887) has received acceptance for its full circulation application from the CSRC [1][2]. - Lingbao Gold's full circulation application is currently in a supplementary materials status [1][2]. Group 2: Application Details - Lingbao Gold Group's full circulation application was received on January 13, 2026, and is in supplementary materials status [2]. - Sifang Precision's direct overseas listing application was accepted on January 14, 2026, with the underwriting by CMB International and Guosen Securities [2]. - Weili Zhibo's full circulation application was also accepted on January 14, 2026, with legal representation from JunHe Law Offices [2]. - Beijing Extreme Intelligence Technology's full circulation application is in supplementary materials status as of January 16, 2026 [2]. - Jingze Biopharmaceutical's direct overseas listing application is in supplementary materials status as of January 16, 2026, with underwriting by CICC and legal representation from Tian Yuan Law Firm [2]. - Zhenqu Technology's direct overseas listing application was accepted on January 16, 2026, with underwriting by CITIC Securities [2].

Group 1 - The China Securities Regulatory Commission (CSRC) has released a report on the status of domestic companies' overseas securities issuance and listing applications as of January 16, 2026 [1] - Companies such as Sifang Jingchuang and Zhenqu Technology have submitted materials for their Hong Kong IPOs, which have been accepted by the CSRC [1] - Jingze Biopharmaceutical and Lingbao Gold have their applications in a supplementary materials status for their Hong Kong IPOs [1] Group 2 - Sifang Jingchuang's application for direct overseas listing is being processed with the Hong Kong Stock Exchange, and it was accepted on January 14, 2026 [2] - Zhenqu Technology's application for direct overseas listing was also accepted on January 16, 2026 [2] - Lingbao Gold's full circulation application is in supplementary materials status, with the last update on January 13, 2026 [2]

Core Insights - The China Securities Regulatory Commission (CSRC) has released a report on the status of domestic companies' overseas securities issuance and listing applications as of January 16, 2026, indicating various companies' IPO and full circulation statuses [1] Group 1: Company Listings - Sifang Precision (300468) and Zhenqu Technology have submitted materials for a Hong Kong IPO, which have been accepted by the CSRC [1][2] - Jingze Biopharmaceutical's IPO application for Hong Kong is currently in the status of supplementary materials [1][2] - Vailizhibo-B has received acceptance for its full circulation application from the CSRC [1][2] - Lingbao Gold's full circulation application is also in the status of supplementary materials [1][2] Group 2: Application Details - Lingbao Gold Group's full circulation application was received on January 13, 2026, and is currently in supplementary materials status [2] - Shenzhen Sifang Precision's direct overseas listing application was accepted on January 14, 2026 [2] - Nanjing Vailizhibo Biotechnology's full circulation application was accepted on January 14, 2026 [2] - Beijing Jizhi Technology's full circulation application is in supplementary materials status as of January 16, 2026 [2] - Jingze Biopharmaceutical's direct overseas listing application is in supplementary materials status as of January 16, 2026 [2] - Zhenqu Technology's direct overseas listing application has been accepted [2]

Group 1 - The core point of the article highlights the recent decline in the stock price of Sifang Jingchuang, which fell by 5.41% to 34.10 CNY per share, with a trading volume of 8.82 billion CNY and a turnover rate of 4.76%, resulting in a total market capitalization of 180.95 billion CNY [1] - Sifang Jingchuang, established on November 21, 2003, and listed on May 27, 2015, is based in Shenzhen, Guangdong Province. The company primarily provides full-process solutions for financial institutions, focusing on digital transformation innovation and traditional business, with software development and maintenance accounting for 95.86% of its revenue [1] - The company's revenue composition includes 95.86% from software development and maintenance, 3.77% from consulting services, and 0.36% from system integration [1] Group 2 - From the perspective of the top ten circulating shareholders, Huabao Fund's Huabao Zhongzheng Financial Technology Theme ETF (159851) increased its holdings by 334.45 million shares in the third quarter, now holding 694.8 million shares, which represents 1.31% of the circulating shares [2] - The Huabao Zhongzheng Financial Technology Theme ETF (159851) was established on March 4, 2021, with a current scale of 123.19 billion CNY. Year-to-date returns are 6.36%, ranking 2372 out of 5542 in its category, while the one-year return is 30.6%, ranking 2592 out of 4235 [2] - The fund manager of Huabao Zhongzheng Financial Technology Theme ETF, Chen Jianhua, has a tenure of 13 years and 33 days, with the fund's total asset scale at 277.02 billion CNY, achieving a best return of 188.49% during his tenure [3]

Core Viewpoint - Sifang Jingchuang experienced a decline of 4.85% in stock price on January 15, with a trading volume of 2.013 billion yuan, indicating potential market volatility and investor sentiment concerns [1] Financing Summary - On January 15, Sifang Jingchuang had a financing buy amount of 179 million yuan and a financing repayment of 213 million yuan, resulting in a net financing outflow of 34.67 million yuan [1] - The total financing and securities balance for Sifang Jingchuang reached 1.403 billion yuan, with the financing balance accounting for 7.24% of the circulating market value, which is above the 60th percentile of the past year [1] - In terms of securities lending, Sifang Jingchuang repaid 10,800 shares and sold 3,800 shares on January 15, with a selling amount of 138,800 yuan, while the remaining securities lending balance was 97,510 yuan, indicating a lower position compared to the 50th percentile of the past year [1] Company Overview - Sifang Jingchuang, established on November 21, 2003, and listed on May 27, 2015, is located in Shenzhen, Guangdong Province, and primarily provides full-process solutions for financial institutions [2] - The company's main business includes digital transformation innovation and traditional services, with software development and maintenance contributing 95.86% to revenue, while consulting and system integration account for 3.77% and 0.36%, respectively [2] - As of September 30, 2025, Sifang Jingchuang reported a revenue of 453 million yuan, a year-on-year decrease of 14.46%, while the net profit attributable to shareholders was 66.8915 million yuan, reflecting a year-on-year increase of 27.36% [2] Dividend Information - Since its A-share listing, Sifang Jingchuang has distributed a total of 300 million yuan in dividends, with 117 million yuan distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, the top ten circulating shareholders of Sifang Jingchuang include notable ETFs and mutual funds, with significant changes in holdings among various institutional investors [3]